Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapies Targeting Epigenetic Alterations in Acute Kidney Injury-to-Chronic Kidney Disease Transition
Fumiaki Tanemoto, Imari Mimura
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 123-123
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Gene regulation by histone-modifying enzymes under hypoxic conditions: a focus on histone methylation and acetylation
Junil Kim, Hye-Rim Lee, Sun-Ju Yi, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 7, pp. 878-889
Open Access | Times Cited: 41
From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms
Zhiwen Wang, Chun Zhang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10880-10880
Open Access | Times Cited: 39
The Interplay between Immune and Metabolic Pathways in Kidney Disease
Lili Qu, Baihai Jiao
Cells (2023) Vol. 12, Iss. 12, pp. 1584-1584
Open Access | Times Cited: 30
HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression
Lijun Zhang, Fang Chen, Jian Dong, et al.
Redox Biology (2023) Vol. 68, pp. 102939-102939
Open Access | Times Cited: 23
The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis
Na Ren, Wenfeng Wang, Liang Zou, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 12
Molecular Mechanisms of Oxidative Stress in Acute Kidney Injury: Targeting the Loci by Resveratrol
Hina Rashid, Abdulmajeed M. Jali, Mohammad Suhail Akhter, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 3-3
Open Access | Times Cited: 16
Exploring the Therapeutic Significance of microRNAs and lncRNAs in Kidney Diseases
Luis Alberto Bravo-Vázquez, Sujay Paul, Miriam Guadalupe Colín-Jurado, et al.
Genes (2024) Vol. 15, Iss. 1, pp. 123-123
Open Access | Times Cited: 7
The Potential Biotherapeutic Targets of Contrast-Induced Acute Kidney Injury
Alice Cheng, Xiaogang Li
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8254-8254
Open Access | Times Cited: 15
Significance of LncRNAs in AKI-to-CKD transition: A therapeutic and diagnostic viewpoint
Bhupendra Puri, Syamantak Majumder, Anil Bhanudas Gaikwad
Life Sciences (2024) Vol. 342, pp. 122509-122509
Closed Access | Times Cited: 4
VNN1 contributes to the acute kidney injury–chronic kidney disease transition by promoting cellular senescence via affecting RB1 expression
Jia Chen, Hongxiang Lu, Xiaoyue Wang, et al.
The FASEB Journal (2022) Vol. 36, Iss. 9
Closed Access | Times Cited: 16
Still finding ways to augment the existing management of acute and chronic kidney diseases with targeted gene and cell therapies: Opportunities and hurdles
Peter R. Corridon
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 10
Hypoxia and renal fibrosis
Stephanie Naas, Mario Schiffer, Johannes Schödel
AJP Cell Physiology (2023) Vol. 325, Iss. 4, pp. C999-C1016
Closed Access | Times Cited: 10
Sex-specific epigenetic programming in renal fibrosis and inflammation
Prerna Kumar, Heddwen L. Brooks
AJP Renal Physiology (2023) Vol. 325, Iss. 5, pp. F578-F594
Open Access | Times Cited: 9
The role of HDAC3 in inflammation: mechanisms and therapeutic implications
Noah Watson, Sivaraman Kuppuswamy, William Luke Ledford, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Novel dysregulated long non‐coding RNAs in the acute kidney injury‐to‐chronic kidney diseases transition unraveled by transcriptomic analysis
Bhupendra Puri, Syamantak Majumder, Anil Bhanudas Gaikwad
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 3
Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
Fumiaki Tanemoto, Masaomi Nangaku, Imari Mimura
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 14
Epigenetic Mechanisms in Sepsis-Associated Acute Kidney Injury
Marco Fiorentino, R. Philippe, Carmen Palumbo, et al.
Seminars in Respiratory and Critical Care Medicine (2024) Vol. 45, Iss. 04, pp. 491-502
Closed Access | Times Cited: 2
Demethylation of H3K9 and H3K27 Contributes to the Tubular Renal Damage Triggered by Endoplasmic Reticulum Stress
Paula Díaz-Bulnes, María Laura Sáiz, Viviana Corte-Iglesias, et al.
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1355-1355
Open Access | Times Cited: 11
MicroRNA-103a-3p enhances sepsis-induced acute kidney injury via targeting CXCL12
Gaihong Ding, Jinhua An, Luyao Li
Bioengineered (2022) Vol. 13, Iss. 4, pp. 10288-10298
Open Access | Times Cited: 8
Arginine‐methylated c‐Myc affects mitochondrial mitophagy in mouse acute kidney injury via Slc25a24
Ying Liu, Naiquan Liu, Ping He, et al.
Journal of Cellular Physiology (2024)
Closed Access | Times Cited: 1
Still Finding Ways to Augment the Existing Management of Acute and Chronic Kidney Diseases with Targeted Gene and Cell Therapies: Opportunities and Hurdles
Peter R. Corridon
(2023)
Open Access | Times Cited: 4
Genomic insights into renal diseases: advancements and implications
Nicholas Aderinto, Gbolahan Olatunji, Emmanuel Kokori, et al.
The Egyptian Journal of Internal Medicine (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 1
Harnessing the Full Potential of Multi-Omic Analyses to Advance the Study and Treatment of Chronic Kidney Disease
Claire Hill, Ione Ávila-Palència, Alexander P. Maxwell, et al.
Frontiers in Nephrology (2022) Vol. 2
Open Access | Times Cited: 7
Hypoxia‐inducible lncRNA MIR210HG promotes HIF1α expression by inhibiting miR ‐93‐5p in renal tubular cells
Hanako Saigusa, Imari Mimura, Yu Kurata, et al.
FEBS Journal (2023) Vol. 290, Iss. 16, pp. 4040-4056
Open Access | Times Cited: 3
Dznep, a histone modification inhibitor, inhibits HIF1α binding to TIMP2 gene and suppresses TIMP2 expression under hypoxia
Tomotaka Yamazaki, Imari Mimura, Yu Kurata, et al.
Physiological Reports (2023) Vol. 11, Iss. 17
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top